Arvest Bank Trust Division’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.22M Sell
28,653
-30,236
-51% -$1.64M 0.06% 131
2026
Q1
$3.7M Sell
58,889
-719
-1% -$57.5K 0.2% 74
2025
Q4
$5.68M Sell
59,608
-64,955
-52% -$6.37M 0.31% 64
2025
Q3
$12.2M Sell
124,563
-702
-0.6% -$72.7K 0.67% 42
2025
Q2
$13.5M Buy
125,265
+204
+0.2% +$20.6K 0.78% 37
2025
Q1
$12.6M Buy
+125,061
New +$12.6M 0.8% 42

Other funds holding BSX

Arvest Bank Trust Division's BSX Position: Q2 2026 in Review

Arvest Bank Trust Division reduced its Boston Scientific (BSX) stake by 51% in Q2 2026, selling an estimated $1.64M and leaving 28,653 shares worth $1.22M. The position accounts for 0.06% of the portfolio, ranked #131.

Arvest Bank Trust Division first reported a position in BSX in Q1 2025 and has held it in 6 quarters since. The position peaked at $13.5M in Q2 2025. 1,487 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Arvest Bank Trust Division held 28,653 shares of Boston Scientific worth $1.22M as of Q2 2026.
  • Arvest Bank Trust Division sold 30,236 Boston Scientific shares in Q2 2026, an estimated $1.64M.
  • Boston Scientific made up 0.06% of Arvest Bank Trust Division's portfolio in Q2 2026, its #131 holding.
  • Arvest Bank Trust Division first reported a position in Boston Scientific in Q1 2025 and has held it in 6 quarters since.
  • Arvest Bank Trust Division's Boston Scientific position peaked at $13.5M in Q2 2025.
  • 1,487 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Arvest Bank Trust Division's 13F filing for Q2 2026, filed 13 Aug 2026.